TREATMENT PATTERNS AMONG LOWER-INCOME INDIAN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATIONS OR ALK REARRANGEMENTS

被引：2
|
作者：
Vashistha, Vishal
Garg, Avneet
Iyer, Hariharan
Jain, Deepali
Madan, Karan
Guleria, Randeep
Mohan, Anant
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1621
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1869A / 1869A
页数：1
相关论文
共 50 条
  • [11] Lower Risk of Hypercoagulability in Non-Small Cell Lung Cancer Patients with EGFR Mutations
    Ohara, S.
    Suda, K.
    Takemoto, T.
    Nishino, M.
    Chiba, M.
    Fujino, T.
    Hamada, A.
    Koga, T.
    Soh, J.
    Misudomi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S653 - S653
  • [12] Prognostic significance of immunotherapy in postoperative recurrent non-small cell lung cancer without EGFR mutations or ALK rearrangements
    Shigefuku, Shunsuke
    Takahashi, Satoshi
    Hagiwara, Masaru
    Kakihana, Masatoshi
    Ohira, Tatsuo
    Ikeda, Norihiko
    JOURNAL OF THORACIC DISEASE, 2024, 16 (06) : 3583 - 3592
  • [13] Adjuvant and neo-adjuvant therapy for non-small cell lung cancer without EGFR mutations or ALK rearrangements
    Takenaka, Masaru
    Kuroda, Koji
    Tanaka, Fumihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, 30 (02) : 215 - 228
  • [14] ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non-Small Cell Lung Cancer
    Gainor, Justin F.
    Varghese, Anna M.
    Ou, Sai-Hong Ignatius
    Kabraji, Sheheryar
    Awad, Mark M.
    Katayama, Ryohei
    Pawlak, Amanda
    Mino-Kenudson, Mari
    Yeap, Beow Y.
    Riely, Gregory J.
    Iafrate, A. John
    Arcila, Maria E.
    Ladanyi, Marc
    Engelman, Jeffrey A.
    Dias-Santagata, Dora
    Shaw, Alice T.
    CLINICAL CANCER RESEARCH, 2013, 19 (15) : 4273 - 4281
  • [15] Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    He, Jinghua
    Pericone, Christopher D.
    Vanderpoel, Julie
    ADVANCES IN THERAPY, 2022, 39 (07) : 3347 - 3360
  • [16] Real-World Patient Characteristics, Treatment Patterns, and Mutation Testing Patterns Among US Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Jinghua He
    Christopher D. Pericone
    Julie Vanderpoel
    Advances in Therapy, 2022, 39 : 3347 - 3360
  • [17] EGFR/ALK Mutations in Stage III Non-small Cell Lung Cancer Patients Received Chemoradiotherapy
    Nyaw, S. F.
    Tin, W. Y.
    Lo, S. H.
    Tung, Y.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S759 - S760
  • [18] EGFR inhibitors as adjuvant therapy for resected non-small cell lung cancer harboring EGFR mutations
    Tang, Wenjie
    Li, Xiaolin
    Xi, Xueqi
    Sun, Xindong
    Liu, Jie
    Zhang, Jian
    Wang, Chungang
    Yu, Jinming
    Xie, Peng
    LUNG CANCER, 2019, 136 : 6 - 14
  • [19] Afatinib vs. Osimertinib as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer Harboring EGFR Mutations
    Hoang, T. T. A.
    Nguyen, T. T. T.
    Pham, C. T. M.
    Dong, H. Q.
    Nguyen, K. T.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S626 - S627
  • [20] Treatment of Non-Small Cell Lung Cancer with Atypical EGFR Mutations
    Leah Wells
    Angel Qin
    Current Treatment Options in Oncology, 2023, 24 : 1802 - 1814
12345